Targeting NEK2 as a promising therapeutic approach for cancer treatment.

Fang, Yanfen; Zhang, Xiongwen

Fang, Yanfen; Zhang, Xiongwen.

Affiliation

Fang Y; a Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University , Shanghai , China.
Zhang X; a Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University , Shanghai , China.

Cell Cycle ; 15(7): 895-907, 2016.

Article in En | MEDLINE | ID: mdl-27019372

Subject(s)

NIMA-Related Kinases/antagonists & inhibitors; NIMA-Related Kinases/physiology; Neoplasms/therapy; Carcinogenesis; Humans; NIMA-Related Kinases/metabolism; Oncogene Proteins/metabolism; Signal Transduction

Key words

Cancer; NEK2; centrosome; inhibitor; mitosis; oncogenic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: NIMA-Related Kinases / Neoplasms Limits: Humans Language: En Journal: Cell Cycle Year: 2016 Document type: Article Affiliation country: China Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google